home / stock / hims / hims news


HIMS News and Press, Hims & Hers Health Inc. Class A From 05/22/24

Stock Information

Company Name: Hims & Hers Health Inc. Class A
Stock Symbol: HIMS
Market: NYSE
Website: forhims.com

Menu

HIMS HIMS Quote HIMS Short HIMS News HIMS Articles HIMS Message Board
Get HIMS Alerts

News, Short Squeeze, Breakout and More Instantly...

HIMS - Hims & Hers Is Changing the Game

2024-05-22 04:36:00 ET Hims & Hers (NYSE: HIMS) has been a great growth stock since coming public, but it's now starting to turn a profit. In this video, Travis Hoium highlights the company's financials and why the launch of GLP-1 medications could be a game-changer. *Stoc...

HIMS - Where are the Opportunities in (HIMS)

2024-05-21 15:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HIMS - Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds

2024-05-21 09:21:57 ET More on Eli Lilly, Novo Nordisk Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Eli Lilly inks radiopharma deal wort...

HIMS - Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

2024-05-21 08:15:00 ET Summary Hims & Hers Health's share price increased by over 25% after announcing the availability of compounded GLP-1 agonist weight loss drugs at a fraction of the price of branded drugs. The company aims to capitalize on the shortages of the branded dru...

HIMS - SCPX, XTIA and CRVO among mid-day movers

2024-05-20 13:12:18 ET More on mid-day movers & stocks. CervoMed: H2 2024 Data For DLB Program A Major Inflection Point Scorpius gains on cGMP facility validation for microbial manufacturing Scorpius prices public offering of units to raise $6M Historical...

HIMS - The case for the overvalued Hims & Hers stock

2024-05-20 11:38:29 ET Hims & Hers Health (NYSE: HIMS) stock price is doing well, helped by its strong growth and demand for its core products. It soared by over 30% this year and by more than 112% this year. It has also surged by over 37% in the past 12 months, giving it a market c...

HIMS - Hims & Hers Health Inc. (NYSE: HIMS) Near Top of Volume Charts in Monday Trading

Hims & Hers Health, Inc. (NYSE: HIMS) is one today's most active stocks by volume. So far today, approximately 37.9M shares of Hims & Hers Health, Inc. have been exchanged, as compared to an average 30-day volume of 7.68M shares. Hims & Hers Health, Inc. operates a multi-specialty ...

HIMS - Hims & Hers Health and BTC Digital among Consumer Staples movers

2024-05-20 11:09:49 ET More on Consumer Staples XLP: Not In The Spotlight Amid Market Uncertainty XLP: Expensive With Underperformance Risk XLP: Rotate Into This Lagging Sector Walmart remains least shorted S&P 500 consumer staple stock in April 1...

HIMS - Hims & Hers surges on cheap compounded versions of Novo Nordisk's semaglutide

2024-05-20 10:15:35 ET More on Hims & Hers Health 10 Solid Reasons To Buy Hims & Hers Stock Hims & Hers: Strong Operating Leverage And Profitability Inflection Hims & Hers: The Growth Story, Coupled With Expanding Profitability, Promises Exponential G...

HIMS - Hims & Hers surges on cheap compounded versions of Novo Nordisk's semagluitide

2024-05-20 10:11:34 ET More on Hims & Hers Health 10 Solid Reasons To Buy Hims & Hers Stock Hims & Hers: Strong Operating Leverage And Profitability Inflection Hims & Hers: The Growth Story, Coupled With Expanding Profitability, Promises Exponential G...

Previous 10 Next 10